Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the…
Browsing: BioTech
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert…
On June 1, 2022, TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement…
An osteoporotic fracture occurs every three seconds worldwide. With more than 50 per cent of the world’s hip fractures expected…
9-month revenue up nearly 12-fold to RM22.03 million Profit supported by higher margin immunotherapy and cell therapies Malaysian Genomics Resource…
Q&M Dental Group (Singapore) Limited, a leading private dental healthcare group in Asia, reported net profit excluding other gains or…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased…
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can…
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced…
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri…
Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage…
Legend Capital’s portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for…
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
As the pandemic continued to affect the market, China Biotech Services (HKG: 8037), which owns one of the largest nucleic…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for…
Malaysian Genomics, airasia Super App, Speedoc and Unique Remedy Join Hands to Offer Health Solutions to airasia Super App’s 51…
EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the…